Ethosuximide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00593 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | nephrogenic diabetes insipidus | KG + DL |
| 3 | insomnia (disease) | KG + DL |
| 4 | familial mesial temporal lobe epilepsy with febrile seizures | KG + DL |
| 5 | epilepsy, childhood absence, susceptibility to | KG + DL |
| 6 | diabetes insipidus, nephrogenic, X-linked | KG + DL |
| 7 | Lafora disease | KG + DL |
| 8 | renal tubule disease | KG + DL |
| 9 | Senior-Boichis syndrome | KG + DL |
| 10 | psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome | KG + DL |
| 11 | progressive myoclonic epilepsy | KG + DL |
| 12 | Jeavons syndrome | KG + DL |
| 13 | generalized epilepsy with febrile seizures | KG + DL |
| 14 | RHYNS syndrome | KG + DL |
| 15 | cranioectodermal dysplasia | KG + DL |
| 16 | Wernicke-Korsakoff syndrome | KG + DL |
| 17 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 18 | Unverricht-Lundborg syndrome | KG + DL |
| 19 | King-Denborough syndrome | KG + DL |
| 20 | trigeminal nerve neoplasm | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.